Related Experiment Video
Updated: Apr 16, 2026
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer
1Department of General Surgery, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, China
Abstract:
Chemoresistance is the most common cause of chemotherapy failure during breast cancer (BCA) treatment. It is generally known that the mechanisms of chemoresistance in tumors involve multiple genes and multiple signaling pathways,; if appropriate drugs are used to regulate the mechanisms at the gene level, it should be possible to effectively reverse chemoresistance in BCA cells. It has been confirmed that chemoresistance in BCA cells could be reversed by ginsenoside Rh2 (G-Rh2). Preliminary studies of our group identified some drug- resistance specific miRNA. Accordingly, we proposed that G-Rh2 could mediate drug-resistance specific miRNA and corresponding target genes through the gene regulatory network; this could cut off the drug-resistance process in tumors and enhance treatment effects. G-Rh2 and breast cancer cells were used in our study. Through pharmaceutical interventions, we could explore how G-Rh2 could inhibit chemotherapy resistance in BCA, and analyze its impact on related miRNA and target genes. Finally, we will reveal the anti-resistance molecular mechanisms of G-Rh2 from a different angle in miRNA-mediated chemoresistance signals among cells.
Insights
Ginsenoside Rh2 (G-Rh2) reverses breast cancer (BCA) chemoresistance by regulating drug-resistance specific microRNAs (miRNAs) and their target genes. This study reveals G-Rh2
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Chemoresistance is a primary cause of treatment failure in breast cancer (BCA).
- Tumor chemoresistance involves complex gene and signaling pathway interactions.
- Targeting gene-level mechanisms offers a strategy to overcome BCA chemoresistance.
Purpose of the Study:
- To investigate if ginsenoside Rh2 (G-Rh2) can reverse chemoresistance in BCA cells.
- To explore the role of G-Rh2 in mediating drug-resistance specific microRNAs (miRNAs) and their target genes.
- To elucidate the molecular mechanisms underlying G-Rh2's anti-resistance effects in BCA.
Main Methods:
- Utilized breast cancer cells and G-Rh2 for pharmaceutical interventions.
- Analyzed the impact of G-Rh2 on chemoresistance, related miRNAs, and target genes.
- Investigated miRNA-mediated chemoresistance signaling pathways.
Main Results:
- Confirmed that G-Rh2 can reverse chemoresistance in BCA cells.
- Identified specific drug-resistance related miRNAs modulated by G-Rh2.
- Demonstrated G-Rh2's potential to disrupt chemoresistance via miRNA-target gene networks.
Conclusions:
- Ginsenoside Rh2 (G-Rh2) effectively reverses breast cancer chemoresistance.
- G-Rh2 acts by modulating specific drug-resistance miRNAs and their target genes.
- This highlights a novel miRNA-mediated mechanism for G-Rh2's anti-cancer effects.
More Related Videos
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:15Experimental RNAi